Form 13-F position report

BIOCEPT INC

Reported by MORGAN STANLEY

BIOC CUSIP 09072V501 Manager CIK 0000895421

Reported 0 shares, down 6 (100.0%) from the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 10 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 35000
2021-12-31 6000
2022-03-31 4000
2022-06-30 0
2022-09-30 0
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for BIOCEPT INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -6 (-100.0%) 0 $0 2023-02-14
Q3 2022 New 6 +6 (0.0%) 0 $0 2022-11-14
Q2 2022 Reduced 0 -1,900 (-100.0%) 0 $0 2022-08-15
Q1 2022 Added 1,900 +80 (4.4%) < 0.01% $4,000 2022-05-13
Q4 2021 Reduced 1,820 -7,046 (-79.5%) < 0.01% $6,000 2022-02-14
Q3 2021 Reduced 8,866 -169,059 (-95.0%) < 0.01% $35,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

32 managers reported BIOCEPT INC for Q4 2022.

Managers reporting BIOCEPT INC in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 617,984 +374 < 0.01% $327,532 10 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 162,300 -6,100 < 0.01% $86,000 6 qtrs
BlackRock Inc Unchanged 157,913 0 < 0.01% $83,694 10 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 137,498 -374 < 0.01% $72,000 10 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 109,436 0 < 0.01% $58,001 4 qtrs
Connective Capital Management LLC New 108,280 +108,280 0.02% $57,388 1 qtr
STATE STREET CORPORATION Unchanged 40,596 0 < 0.01% $21,516 7 qtrs
SABBY MANAGEMENT LLC Unchanged 30,502 0 0.01% $16,166 9 qtrs
NORTHERN TRUST CORPORATION Unchanged 26,818 0 < 0.01% $14,214 10 qtrs
Taylor & Morgan Wealth Management LLC Unchanged 26,000 0 0.01% $13,780 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.